Does Inflammation Enhance Rengeneration?

炎症会增强再生吗?

基本信息

  • 批准号:
    8464541
  • 负责人:
  • 金额:
    $ 30.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-08-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): It is well known that prolonged inflammation hinders the optimal goal of wound repair, namely prompt closure of the wound with minimal scarring. However, the objective of tissue regeneration (as opposed to wound repair) is to reconstitute and replace damaged tissue with a functional biological replica of the lost tissue without scarring. In this latter case, the role of inflammation is not well established for the simple reason that most mammals including humans have rarely demonstrated any capacity for regeneration (with the exception of the liver) precluding experimental approaches. Based upon our observations in a mouse model of appendage injury (ear hole closure in the MRL mouse), this proposal will address the counter-intuitive possibility that enhancing at least some aspects of inflammation will re-direct wound healing towards regeneration. We will also examine the use of novel biomaterials to locally harness key aspects of the inflammatory response and facilitate tissue regeneration. MRL mice have been shown to be robust regenerators of multiple tissue types and we have consistently noted that regeneration is accompanied by intense and prolonged inflammation at the injury site. Administration of the anti-inflammatory COX2 inhibitor meloxicam inhibits MRL ear hole closure suggesting that inflammation may be functionally involved in appendage regeneration. We directly tested this possibility in non-regenerating C57BL/6 mice by topically applying the pro-inflammatory drug imiquimod, a toll-like receptor (TLR) ligand, to injury sites in two wound models: ear hole healing and digit amputation. In both cases, a positive regenerative result ensued. In this proposal, we will 1) examine the TLRs involved in the MRL regenerative response and 2) attempt to stimulate those predominant TLRs using select TLR ligands applied topically to elicit a regenerative response in the non-regenerating C57BL/6 mouse. The level of inflammation and regenerative response will be determined at the transcript, protein, cellular and tissue levels. 3) We will apply those TLR ligands not only topically but will generate chemically conjugated compounds to a biomaterial. The latter will provide us with a novel injectable in-situ forming macromolecular biomaterial (NCL hydrogel) that can be used for injuries that are not only surface injuries but deep injuries as well. We envision that this approach of mimicking the inflammatory microenvironment of a healing wound will allow for biomaterial degradation accompanied by tissue regeneration, leading in the future to new clinical modalities for tissue regeneration.
描述(由申请人提供):众所周知,持续的炎症会阻碍伤口修复的最佳目标,即以最小的疤痕迅速关闭伤口。然而,组织再生的目标(与伤口修复相反)是重建和替换受损组织,用失去组织的功能生物复制品而不留下疤痕。在后一种情况下,炎症的作用还没有很好地确定,原因很简单,包括人类在内的大多数哺乳动物很少表现出任何再生能力(肝脏除外),这就排除了实验方法。根据我们对附肢损伤小鼠模型(MRL小鼠耳孔闭合)的观察,该建议将解决反直觉的可能性,即增强炎症的至少某些方面将重新引导伤口愈合走向再生。我们还将研究使用新型生物材料来局部控制炎症反应的关键方面并促进组织再生。MRL小鼠已被证明是多种组织类型的强大再生者,我们一直注意到再生伴随着损伤部位强烈和长期的炎症。抗炎COX2抑制剂美洛昔康可抑制MRL耳孔闭合,提示炎症可能在功能上参与了附件再生。我们在非再生C57BL/6小鼠中直接测试了这种可能性,方法是将促炎药物咪喹莫特(一种toll样受体(TLR)配体)局部应用于两种伤口模型的损伤部位:耳孔愈合和手指截肢。在这两种情况下,都出现了积极的再生结果。在本提案中,我们将1)检查参与MRL再生反应的TLR, 2)尝试使用选择的TLR配体局部应用来刺激那些主要的TLR,以引发非再生C57BL/6小鼠的再生反应。炎症和再生反应的水平将在转录物、蛋白质、细胞和组织水平上决定。3)我们将这些TLR配体不仅局部应用,而且将生成化学偶联化合物到生物材料中。后者将为我们提供一种新型的可注射原位形成的大分子生物材料(NCL水凝胶),不仅可以用于表面损伤,也可以用于深部损伤。我们设想,这种模拟愈合伤口炎症微环境的方法将允许生物材料降解伴随着组织再生,从而在未来引领组织再生的新临床模式。

项目成果

期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Cartilage boundary lubricating ability of aldehyde modified proteoglycan 4 (PRG4-CHO).
醛修饰蛋白聚糖4(PRG4-CHO)的软骨边界润滑能力。
  • DOI:
    10.1016/j.joca.2012.09.016
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    7
  • 作者:
    Abubacker,S;Ham,HO;Messersmith,PB;Schmidt,TA
  • 通讯作者:
    Schmidt,TA
ECM-incorporated hydrogels cross-linked via native chemical ligation to engineer stem cell microenvironments.
  • DOI:
    10.1021/bm400728e
  • 发表时间:
    2013-09-09
  • 期刊:
  • 影响因子:
    6.2
  • 作者:
    Jung, Jangwook P.;Sprangers, Anthony J.;Byce, John R.;Su, Jing;Squirrell, Jayne M.;Messersmith, Phillip B.;Eliceiri, Kevin W.;Ogle, Brenda M.
  • 通讯作者:
    Ogle, Brenda M.
Oxygen, Metabolism, and Regeneration: Lessons from Mice.
  • DOI:
    10.1016/j.molmed.2017.08.008
  • 发表时间:
    2017-11
  • 期刊:
  • 影响因子:
    13.6
  • 作者:
    Heber-Katz E
  • 通讯作者:
    Heber-Katz E
Drug delivery and epimorphic salamander-type mouse regeneration: A full parts and labor plan.
  • DOI:
    10.1016/j.addr.2018.02.006
  • 发表时间:
    2018-04
  • 期刊:
  • 影响因子:
    16.1
  • 作者:
    Heber-Katz E;Messersmith P
  • 通讯作者:
    Messersmith P
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Ellen s. Heber-Katz其他文献

Ellen s. Heber-Katz的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Ellen s. Heber-Katz', 18)}}的其他基金

Regenerative wound healing via inflammation-modulating biomaterials
通过炎症调节生物材料实现伤口再生愈合
  • 批准号:
    8993948
  • 财政年份:
    2015
  • 资助金额:
    $ 30.84万
  • 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
  • 批准号:
    9009892
  • 财政年份:
    2013
  • 资助金额:
    $ 30.84万
  • 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
  • 批准号:
    9086307
  • 财政年份:
    2013
  • 资助金额:
    $ 30.84万
  • 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
  • 批准号:
    8899472
  • 财政年份:
    2013
  • 资助金额:
    $ 30.84万
  • 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
  • 批准号:
    8722513
  • 财政年份:
    2013
  • 资助金额:
    $ 30.84万
  • 项目类别:
(PQA2) MAMMALIAN REGENERATION, HIGH FAT DIETS, AND BREAST CANCER: A COMMON LINK?
(PQA2) 哺乳动物再生、高脂肪饮食和乳腺癌:共同的联系?
  • 批准号:
    8590786
  • 财政年份:
    2013
  • 资助金额:
    $ 30.84万
  • 项目类别:
Regenerative wound healing via inflammation-modulating biomaterials
通过炎症调节生物材料实现伤口再生愈合
  • 批准号:
    8107808
  • 财政年份:
    2011
  • 资助金额:
    $ 30.84万
  • 项目类别:
Regenerative wound healing via inflammation-modulating biomaterials
通过炎症调节生物材料实现伤口再生愈合
  • 批准号:
    8258251
  • 财政年份:
    2011
  • 资助金额:
    $ 30.84万
  • 项目类别:
Regenerative wound healing via inflammation-modulating biomaterials
通过炎症调节生物材料实现伤口再生愈合
  • 批准号:
    8656970
  • 财政年份:
    2011
  • 资助金额:
    $ 30.84万
  • 项目类别:
Regenerative wound healing via inflammation-modulating biomaterials
通过炎症调节生物材料实现伤口再生愈合
  • 批准号:
    8454537
  • 财政年份:
    2011
  • 资助金额:
    $ 30.84万
  • 项目类别:

相似海外基金

Understanding the Heightened Amputation Risk Among People Experiencing Homelessness: A Population-based Cohort Study
了解无家可归者截肢风险升高:一项基于人群的队列研究
  • 批准号:
    480010
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Operating Grants
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246672
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Standard Grant
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246671
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Standard Grant
Advancing measurement of physical function in upper limb amputation
推进上肢截肢身体功能的测量
  • 批准号:
    10749083
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
Collaborative Research: An Integrated, Proactive, and Ubiquitous Prosthetic Care Robot for People with Lower Limb Amputation: Sensing, Device Designing, and Control
合作研究:针对下肢截肢患者的集成、主动、无处不在的假肢护理机器人:传感、设备设计和控制
  • 批准号:
    2246673
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Standard Grant
Establishing the Relationship Between Muscle Quality and Joint Loading for Individuals with Transtibial Amputation
建立小腿截肢患者的肌肉质量和关节负荷之间的关系
  • 批准号:
    10677236
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
Preventing Amputation through Management of Diabetic Foot; Working with Industry to generate supply chains in an LMIC setting (Uganda) for low-cost fo
通过糖尿病足管理预防截肢;
  • 批准号:
    2883969
  • 财政年份:
    2023
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Studentship
Myoelectric upper limb prosthesis with multiple degrees of freedom using targeted muscle reinnervation surgery for traumatic amputation
多自由度肌电上肢假肢,采用靶向肌肉神经支配手术治疗创伤性截肢
  • 批准号:
    22K16723
  • 财政年份:
    2022
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Diabetes Lower Extremity Complications Research and Training Network in Foot Ulcer and Amputation Prevention (DIALECT)
糖尿病下肢并发症足部溃疡和截肢预防研究与培训网络 (DIALECT)
  • 批准号:
    EP/X02699X/1
  • 财政年份:
    2022
  • 资助金额:
    $ 30.84万
  • 项目类别:
    Research Grant
An automatically-adjusting prosthetic socket for people with transtibial amputation
适用于小腿截肢患者的自动调节假肢接受腔
  • 批准号:
    10364108
  • 财政年份:
    2022
  • 资助金额:
    $ 30.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了